Intravitreal anti-VEGF treatment in eyes with combined choroidal neovascularisation and vitreomacular traction syndrome

British Journal of Ophthalmology

Volumn 94, Issue 9, 2010, Pages 1205-1210

  Rotsos, T ^a   Sagoo, M S ^a,b   DaCruz, L ^a   Andrews, R ^a   Dowler, J ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; AGED; ANGIOID STREAK; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; DELAYED DIAGNOSIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITREOMACULAR TRACTION SYNDROME; ANTAGONISTS AND INHIBITORS; CHOROIDAL NEOVASCULARIZATION; COMPLICATION; INTRALESIONAL DRUG ADMINISTRATION; MIDDLE AGED; SYNDROME; VERY ELDERLY; VITREOUS BODY DETACHMENT; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; SYNDROME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS DETACHMENT; WET MACULAR DEGENERATION;

EID: 77956564080     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.173765     Document Type: Article

References (28)

1. Reese AB, Jones IS, Cooper WC. Vitreomacular traction syndrome confirmed histologically. Am J Ophthalmol 1970;69:975-7.
2. Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome. Am J Ophthalmol 1995;119:55-61.
3. Margherio RR, Trese MT, Margherio AR, et al. Surgical management of vitreomacular traction syndromes. Ophthalmology 1989;96:1437-45.
4. Massin P, Duguid G, Erginay A, et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 2003;135:169-77. (Pubitemid 36151793)
5. Schmidt-Erfurth U, Leitgeb RA, Michels S, et al. Three-dimensional ultrahighresolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 2005;46:3393-402. (Pubitemid 44264330)
6. Quaranta-El Maftouhi M, Mauget-Faysse M. Anomalous vitreoretinal adhesions in patients with exudative age-related macular degeneration: an OCT study. Eur J Ophthalmol 2006;16:134-7.
7. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
8. Mojana F, Cheng L, Bartsch DU, et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol 2008;146:218-27.
9. Krebs I, Brannath W, Glittenberg C, et al. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol 2007;144:741-6.
10. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
11. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
12. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44.
13. Giansanti F, Virgili G, Bini A, et al. Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study. Eur J Ophthalmol 2007;17:230-7.
14. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991;109:1242-57.
15. Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990;10:1-8. (Pubitemid 20201879)
16. Yannuzzi LA, Freund KB, Takahashi BS. Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 2008;28:375-84.
17. Ondes F, Yilmaz G, Acar MA, et al. Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol 2000;44:91-3. (Pubitemid 30029141)
18. Rouvas A, Petrou P, Ladas I, et al. Spontaneous resolution of vitreomacular traction following ranibizumab (Lucentis) injection. Eur J Ophthalmol 2008;18:301-3. (Pubitemid 351692195)
19. Weber-Krause B, Eckardt U. [Incidence of posterior vitreous detachment in eyes with and without age-related macular degeneration. An ultrasonic study] (In German). Ophthalmologe 1996;93:660-5.
20. Schulze S, Hoerle S, Mennel S, et al. Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol 2008;86:470-81.
21. Meyer CH, Toth CA. Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 2001;239:325-33.
22. Spaide RF, Armstrong D, Browne R. Choroidal neovascularization in age-related macular degenerationewhat is the cause? Retina 2003;23:595-614.
23. Perichon JY, Brasseur G, Uzzan J. [Ultrasonographic study of posterior vitreous detachment in emmetropic eyes] (In Frence). J Fr Ophtalmol 1993;16:538-44.
24. Hayreh SS, Jonas JB. Posterior vitreous detachment: clinical correlations. Ophthalmologica 2004;218:333-43.
25. Gallemore RP, Jumper JM, McCuen BW 2nd, et al. Diagnosis of vitreoretinal adhesions in macular disease with optical coherence tomography. Retina 2000;20:115-20.
26. Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009;148:43-58 e1.
27. Schmidt JC, Mennel S, Horle S, et al. High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy. Br J Ophthalmol 2006;90:1361-2.
28. Lambert HM, Capone A Jr, Aaberg TM, et al. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1992;113:257-62.